Additionally, tumor heterogeneity and biological complexity frequently limit the efficacy of monotherapies, necessitating the development of multifunctional delivery systems.<h4>Results</h4>We engineered a dual microenvironment-responsive albumin to integrate conditional PROTAC activation with metabolic starvation and ferroptosis for synergistic antitumor efficacy within a unified therapeutic cascade. Here, ALB is linked to neoplasm.